PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmicrBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Microbiology
 
BMC Microbiol. 2012; 12: 64.
Published online May 1, 2012. doi:  10.1186/1471-2180-12-64
PMCID: PMC3438138
Clonal complexes and virulence factors of Staphylococcus aureus from several cities in India
Srikanth Shambat,1,2 Savitha Nadig,1 Sushma Prabhakara,1 Michele Bes,3,4 Jerome Etienne,3,4 and Gayathri Arakerecorresponding author1
1Society for Innovation and Development, Department of Microbiology, Indian Institute of Science, Bengaluru 560012, India
2Karolinska Institutet, Center for Infectious Medicine F59, Karolinska University Hospital, Huddinge, S-141 86 Stockholm, Sweden
3French National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France
4University of Lyon, Inserm U851, Faculte de Medicine Lyon Est, Lyon, France
corresponding authorCorresponding author.
Srikanth Shambat: srikanthums/at/gmail.com; Savitha Nadig: savitha.nd/at/gmail.com; Sushma Prabhakara: sushmaprabhakara/at/gmail.com; Michele Bes: michele.bes/at/chu-lyon.fr; Jerome Etienne: Jerome.Etienne/at/univ-lyon1.fr; Gayathri Arakere: gayathri.arakere/at/gmail.com
Received April 19, 2011; Accepted April 19, 2012.
Background
Diseases from Staphylococcus aureus are a major problem in Indian hospitals and recent studies point to infiltration of community associated methicillin resistant S. aureus (CA-MRSA) into hospitals. Although CA-MRSA are genetically different from nosocomial MRSA, the distinction between the two groups is blurring as CA-MRSA are showing multidrug resistance and are endemic in many hospitals. Our survey of samples collected from Indian hospitals between 2004 and 2006 had shown mainly hospital associated methicillin resistant Staphylococcus aureus (HA-MRSA) carrying staphylococcal cassette chromosome mec (SCCmec) type III and IIIA. But S. aureus isolates collected from 2007 onwards from community and hospital settings in India have shown SCCmec type IV and V cassettes while several variations of type IV SCCmec cassettes from IVa to IVj have been found in other parts of the world. In the present study, we have collected nasal swabs from rural and urban healthy carriers and pus, blood etc from in patients from hospitals to study the distribution of SCCmec elements and sequence types (STs) in the community and hospital environment. We performed molecular characterization of all the isolates to determine their lineage and microarray of select isolates from each sequence type to analyze their toxins, virulence and immune-evasion factors.
Results
Molecular analyses of 68 S. aureus isolates from in and around Bengaluru and three other Indian cities have been carried out. The chosen isolates fall into fifteen STs with all major clonal complexes (CC) present along with some minor ones. The dominant MRSA clones are ST22 and ST772 among healthy carriers and patients. We are reporting three novel clones, two methicillin sensitive S. aureus (MSSA) isolates belonging to ST291 (related to ST398 which is live stock associated), and two MRSA clones, ST1208 (CC8), and ST672 as emerging clones in this study for the first time. Sixty nine percent of isolates carry Panton- Valentine Leucocidin genes (PVL) along with many other toxins. There is more diversity of STs among methicillin sensitive S. aureus than resistant ones. Microarray analysis of isolates belonging to different STs gives an insight into major toxins, virulence factors, adhesion and immune evasion factors present among the isolates in various parts of India.
Conclusions
S. aureus isolates reported in this study belong to a highly diverse group of STs and CC and we are reporting several new STs which have not been reported earlier along with factors influencing virulence and host pathogen interactions.
S. aureus is a highly versatile gram positive organism capable of being a commensal and causing a variety of diseases such as soft tissue infections, bacterial endocarditis, septicemia and osteomyelitis. The ability of the organism to cause a multitude of infections is probably due to the expression of myriads of different toxins, virulence factors and also cell wall adhesion proteins and staphylococcal superantigen like proteins (ssl) involved in immune-evasion. The emergence of MRSA in most countries of the world is a cause of great concern. Vancomycin resistance, in addition, has left physicians with limited treatment options [1,2].
The distinction between HA- MRSA and CA- MRSA was clear when CA-MRSA were first reported. CA-MRSA originated with individuals in the community who had none of the risk factors from exposure to hospital environment and had distinctly different antibiotic sensitivities than the HA-MRSA which infected hospitalized patients with specific risks of infections. But in the last five years, CA-MRSA have infiltrated the hospitals and are replacing HA-MRSA, mainly in countries where the prevalence of CA-MRSA is high [3].
Methicillin resistance is conferred on the organism by the presence of a unique mobile genetic element called the SCCmec carrying the mecA gene. The SCCmec elements are divided into different types based on the nucleotide differences in two essential components, ccr (cassette chromosome recombinase) gene complex, represented by ccr genes and mec gene complexes. Eight major types of SCCmec elements were reported till recently but three more new types have been added in the past few months from bovine and human origins increasing the total to eleven SCCmec types [4-6]. HA-MRSA isolates contain mainly type I, II, and III SCCmec elements while CA-MRSA contain type IV and V SCCmec elements each of which has several variants. For instance, majority of Indian HA-MRSA collected between 2002 and 2006 contained type III or IIIA SCCmec elements, as previously reported [7,8].
We reported in 2008 the presence of PVL positive ST22 (EMRSA-15) and ST772 (single locus variant of ST1 and belonging to CC1) as major clones in nasal swabs collected in healthy carriers in and around Bengaluru in a small number of samples [9]. Recently, our studies in carriers and individuals with disease from rural and urban areas of Bengaluru showed variants of EMRSA-15 clones [10]. Another study from a tertiary care hospital in Mumbai also demonstrated the presence of EMRSA-15 as a major clone among patients [11]. A second important clone is the PVL-positive ST772 which has been detected in and around Bengaluru, Mumbai (India), Bangladesh and Malaysia [9,11-13]. These two dominant epidemic clones are associated with both CA- and HA-infections in India and seem to have progressively replaced the ST239 clone in hospitals [11].
Aim of this study was to establish the lineage of sensitive and resistant S. aureus strains collected from in and around Bengaluru and three other cities in India, and determine their toxins and virulence factors. In this article, MRSA and MSSA collected either from HA- and CA-infections or carriages were characterized using the microarray system developed by Clonediag® which detects 300 alleles of the S. aureus genome [14]. This characterization complemented those obtained by multi-locus sequence typing (MLST), staphylococcal protein A (spa) typing, pulsed field gel electrophoresis (PFGE), PCR to confirm the SCCmec type, toxin gene content, and antibiograms. The two already-reported ST22 and ST772 clones were detected as MSSA and MRSA. The spreading of ST8 along with an emerging clone of PVL-negative ST672 among Indian CA-MRSA is being reported in this study. The Indian MSSA clones identified were much more diverse and were different from the MRSA clones, except for ST8 and 672 which were detected in both MRSA and MSSA groups. The livestock-associated ST398 related clone (ST291) is reported for the first time in two MSSA isolates.
Carrier and disease S. aureus isolates
Carrier (38) and disease (30) isolates were collected from rural, urban out patient and urban in patient environments and analysis is presented in Table Table11.
Table 1
Table 1
Molecular characteristics of MSSA/MRSA clones from carriers and disease isolates
Twenty six percent of carrier isolates and sixty percent of disease isolates were MRSA. All MRSA carried SCCmec type IV or V. Total of 15 STs were present among all the 68 isolates characterized. All but one sequence type were present in carrier isolates. ST 22, 772, 30, 121, 1208, 199, 672, and 45 were present among disease isolates. ST 5, 6, 7, 39, 72, and 291were present only among carriers. Antibiotic sensitivity to five antibiotics -oxacillin, cefoxitin, erythromycin, gentamicin, and tetracycline were tested on all the strains (data not presented). Isolates belonging exclusively to carrier STs were sensitive to all the antibiotics tested. Predominant methicillin resistant STs were 22 (68%) and 772 (69%) along with small percentage of isolates belonging to ST30, 672 and 1208 carrying 1.5, 3.0 and 4.4 percent of isolates respectively as MRSA. Carrier MRSA isolates were limited to ST22, 772, 30 and 1208 while disease MRSA isolates in addition included ST672. All carrier and disease isolates of ST22 and 772 lineage were PVL and egc positive.
MLST types
Twelve S. aureus CC (15 STs) were identified with three of the clones detected in more than 10% of the isolates (ST22, ST772 and ST121) (Table (Table1).1). New or recently emerging clones were also detected (ST1208 and ST672). Figure Figure11 shows the eBURST analysis and lineages of all sequence types. Details of all the STs follow as given below. CC and STs of MSSA were much more diverse than those of MRSA (12 for MSSA, 5 for MRSA). Isolates belonged to all the 4 agr types. New spa types were detected among MRSA and MSSA isolates of lineages ST672, 772, 45, 121 and 6. PVL genes were detected in 69% of the isolates and egc in 84%. Microarray analysis was performed for representative carrier and disease isolates from each sequence type to determine the virulent factors and toxins.
Figure 1
Figure 1
eBURST analysis of 15 STs present among the Indian Staphylococcus aureus collection.
Microarray
Factors which were common to all isolates when analyzing the microarray results, were as follows: virulence factor genes- α, γ, δ haemolysins, staphylococcal complement inhibitor (scn), aureolysin, sspA, sspB and sspP; MSCRAMMS genes- fnbA, fib, ebpS, vwb, sdrC; Clumping factors A and B; bbp (bone sialo-protein binding protein); map (major histocompatibility complex class II analog protein) and immune-evasion genes- isaB, isdA, imrP, mprF, hysA1, hysA2, set 6, ssl9 were present in all except in one isolate of ST199 and one isolate of ST22, ssl7 absent only in one isolate of ST121. The patterns of presence and absence of virulence and immune evasion factors strictly followed the sequence type. Carrier and disease isolates belonging to a particular ST type had the same patterns. Raw microarray data of 33 isolates is provided as an Additional file 1. In a few cases where results were ambiguous, results have been confirmed with PCRs.
PFGE
Figure Figure2A2A represents PFGE patterns of one representative isolate from each ST and 2B the dendrogram of PFGE depicting the relatedness of patterns based on the similarities derived from the UPGMA and dice coefficients using the Quantity one software. All profiles were different from each other and were distinct patterns characteristic of the ST.
Figure 2
Figure 2
A: PFGE patterns of SmaI  digested isolates showing different sequence types of Indian S. aureus. Lane: 1, 8,15 - NCTC8325, Lane 2 - ST22, Lane 3 - ST6, Lane 4 – ST7, Lane 5 – ST45, Lane 6 – ST1208, (more ...)
CC22-ST22
ST22 is the major clone detected in 28% of the isolates present in both carrier and disease isolates. Methicillin resistance was detected in 68% in both groups, and the MRSA isolates had a SCCmec IV element. PFGE patterns of all ST22 isolates resembled classical EMRSA-15 patterns with 3–4 band differences and were related variants [10]. Spa types from MSSA isolates differed from those of MRSA. ST22 is the clone most resistant to antibiotics with resistance to gentamicin and erythromycin, in MRSA as well as MSSA, both in carriers and infected patients. This clone was agr type I, capsular type 5, PVL and egc positive.
CC1-ST772
This is the second major clone present in our collection detected in 19% of the isolates both in carrier and disease isolates. Methicillin resistance was detected in 69% in both groups and the isolates had a SCCmec V element. Isolates with resistance to gentamicin and erythromycin were found in MRSA only, but both in carriers and infected patients. Spa types from MSSA isolates differed from MRSA. This clone was agr type II, capsular type 5, PVL and egc positive.
CC121-ST120 and ST121
The ST120/121 clones were detected in 10% of the isolates both in carriers and patients. Methicillin resistance as well as resistance to other antibiotics was not detected in any of the isolates. This clone was agr type IV, capsular type 8, PVL and egc positive.
ST672
We are reporting a new sequence type from India, which appears to have the potential to be a founder clone. This clone was detected in 6% of the isolates in both carrier and disease isolates. Methicillin and gentamicin resistance was detected in 2 disease isolates with a SCCmec V element. Spa types from MSSA isolates differed from those of MRSA. This clone was agr type I, capsular type 8, PVL negative and egc and seb positive.
CC8-ST1208 and ST72
ST1208 is a new single locus variant (SLV) of ST8 and ST72 is a double locus variant (DLV). One ST1208 isolate was PVL positive. All three ST1208 MRSA isolates and one ST72 MSSA isolate were resistant to gentamicin and erythromycin. These clones were agr type I, and capsular polysaccharide type 5.
CC30-ST30 and ST39
CC30 was represented by 4 isolates from the community and the hospitals belonging to ST30 and one ST39 carrier isolate (SLV of ST30). Methicillin and erythromycin resistance was detected in one ST30 carrier isolate with SCCmec type IVc. All isolates were agr type III. This is the only SCCmec type IVc isolate belonging to agr type III in our collection with a distinct PFGE pattern different from EMRSA-15. Except for one carrier ST39 MSSA isolate, all isolates were PVL and egc positive and belonged to capsular polysaccharide type 8.
CC398-ST291
This is the first report of two carrier MSSA isolates which are related to S. aureus from bovine origin. ST291 is a DLV of ST398 and spa types t937 and t3096 differed by one repeat unit. No antibiotic resistance was detected. PFGE patterns of these two isolates were very closely related with one band difference. These two isolates contained exotoxin D (etD) and edinB (epidermal cell differentiation inhibitor B) unlike other isolates and were negative for PVL and tst and contained capsular polysaccharide type 5.
CC45-ST45, CC5-ST5, CC15-ST199, ST6 and ST7
These five other STs included 14 isolates with various characteristics. Methicillin resistant isolates were not detected among these STs, as well as other antibiotic resistance determinants. The PVL genes were detected in two isolates. While ST6, 7, 45, and 199 had capsular polysaccharide type 8, CC5 contained type 5.
Differences in SCCmec elements of MRSA isolates
Table Table22 represents the PCR and microarray data for all MRSA (A) and representative carrier and disease isolates belonging to SCCmec type IV and V (B and C) respectively. After determination of mecA gene in all 68 samples, multiplex PCRs were performed for determination of the mec and ccr complexes using primers for amplification of ΔmecR1, IS1272, dcs, ccrA2B2, ccrC, mec C2 complex, subtypes of SCCmec type IV from IVa to IVd and IVh only for MRSA isolates. Various regions of SCCmec type V element from known sequences were also amplified by PCR to further identify SCCmec type V isolates.
Table 2
Table 2
Characteristics of representative SCC mec type IV and V isolates examined by PCR and Microarray
Isolates carrying SCCmec type IV cassettes did not amplify primers specific for IVa, IVb, IVc, IVd and IVh. Previous work from our laboratory has shown several variants of classical EMRSA-15 in PFGE patterns, and the J regions could be different from the known ST22, EMRSA-15 isolates [10]. One ST30 carrier isolate carrying SCCmec type IV has a different PFGE pattern from that of ST22 (Figure (Figure2)2) and amplified primers specific for SCCmec type IVc.
Differences in type V SCCmec elements
SCCmec type V elements were present in three different classes of STs-772, 672 and 1208. PCRs to identify different regions of type V elements (using strain WIS (WBG8318), Genbank accession no. AB121219) and microarray of selected isolates pointed to two different variants of type V element as shown in Table Table22 (B and C). CcrC, mecA and ugpQ (Glycerophosphoryl-diester-Phosphodiesterase next to mecA) were present in all type V isolates while only isolates belonging to ST772 and ST672 carried a second ccrC region in the SCCmecZH47 in the microarray from the mosaic cassette ZH47 reported by Heuser et al [15]. This region was positive by PCR using primers specific for the second ccrC in the SCCmecZH47 region with a size of 435 bp and is identical in sequence to isolates containing composite cassettes of SCCmec type V (5&5 C2). Type V isolates belonging to CC8 did not carry the second ccrC region. SCCmecZH47 also contain ccrA2ccrB2 and a very small truncated mecR region which did not amplify in our ST772 and ST672 isolates by PCR and microarray. Apart from amplifying the mecC2 complex upstream of mecA, none of the primers designed for several different regions of SCCmec type V based on sequences from WIS strain, amplified DNA from our type V isolates indicating that the J regions could be different. All isolates belonging to ST672 and 772 amplified primers for both hsdR and hsdM regions while ST1208 isolates did not amplify the hsdR region indicating there could be changes in this region as well (Table (Table2A).2A). No DNA fragments targeting hsdS, which determine the specificity of restriction modification system, were amplified with DNAs of all isolates. The other genes indicated in Table Table2C2C are selected from the microarray data to examine the differences among isolates belonging to different STs.
We have characterized S. aureus isolates from different cities in India, which belong to a wide variety of STs from healthy carriers and individuals with simple to complicated diseases. Even in a small number of isolates (68), there were 15 different STs (including the two isolates resembling S. aureus from animal origin) and MSSA isolates were the most diverse. Among the MRSA isolates, the predominant ST were 22, 772, 672, 8 and 30. ST672 is a new emerging clone with only two isolates reported from Australia and U.S. While EMRSA-15 (ST22) appeared as a major clone in Indian hospitals with SCCmec type IV element, ST772, 672 and 8 are emerging as SCCmec type V. It is evident from our studies that at least two different types of SCCmec type V elements exist in isolates belonging to three distinct STs.
The most obvious bias in the study is the limited number of isolates collected, but our results are in part concordant with those in the literature: the two major MRSA STs (STs22 and STs772) reported earlier in India [9,11]. Many of the other MSSA and two of the MRSA STs are being reported for the first time.
The antibiotic sensitivity data (not shown) indicates that majority of carrier MSSA were sensitive to all five tested antibiotics. Antibiotic resistant determinants were found mainly in carrier and disease MRSA isolates, but few ST22 carrier and disease MSSA isolates also had resistance determinants for gentamicin and /or erythromycin. For few MRSA isolates (STs 22, 772, 672, and 8) containing the mecA gene, MICs for oxacillin and cefoxitin were 4–8 and 8-16 μg/ml respectively while for most other isolates the corresponding values were 8–16 and 16-32 μg/ml (data not shown). We considered these isolates as methicillin resistant as the patient treatment with oxacillin would select for resistance in a heterogeneous population containing the mecA gene. Similar MRSA isolates of ST59 background were found in Taiwan [16] and CC5 lineage in Switzerland among injection drug users. One of the Swiss isolates of CC5 (ZH47) has been reported to have low MIC for oxacillin and sequenced to contain a composite SCCmec cassette with ZH47 region containing a second ccrC. Our isolates of ST772 and ST672 with low level of oxacillin resistance also contain the second ccrC region. The low level of resistance has been attributed to mutations in the mecA promoter region [17].
EMRSA-15 (ST22) has been reported to be replacing HA-MRSA in hospitals in many countries - Germany, Portugal, Singapore, to name just a few [18-20]. In 2003 when we had collected MRSA isolates from Indian hospitals [7,8], majority of them belonged to ST239 with SCCmec type III or IIIA; ST22 now made up 28% of the total in the present collection. A study from Mumbai, India, with larger sample numbers, from a tertiary care hospital also indicates that EMRSA-15 is replacing type III SCCmec containing isolates [11].
ST772 (CC1) has been reported from India, Bangladesh and Malaysia [9,12,13]. Our ST772 isolates and that from Bangladesh have agr type II while CC1 isolates from Malaysia, Australia and U.S. have been reported to be agr type III. Aires de Sousa et al., have reported three sequence types (ST188, ST573, ST1) belonging to CC1, as agr types I, II, and III respectively in a survey of isolates from Portuguese hospitals and community [21]. CC1 lineage itself seems to be changing from an independent founder to a sub-founder and CC15 is evolving as the founder strain from the eBURST analysis (Figure (Figure1).1). ST573 appears to be the link between the founder and sub-founder clones. CC1 appears to be evolving along with the agr locus rapidly with numerous recombinations which is unusual, as agr types are usually uniform in a CC.
ST672 has not been reported from any of the Asian countries till now. The MLST data base reports one isolate from Australia and one from U.S. It appears important to determine if this clone will persist as a minor clone or not. ST772 and ST672 MRSA isolates carried the same composite type V SCCmec elements unlike the ones carried by ST1208 isolates (Table (Table2).2). Among the numerous results obtained by the microarrays, collagen binding adhesion (cna) was absent in ST672 and present in 772 (raw data of microarray provided). The capsular polysaccharide types 8 and 5 were present in ST672 and 772 respectively.
The large diversity in the STs present in the MSSA isolates confirmed the highly diverse MSSA population reported from Shanghai, China, recently which included ST5, 6, 7, 30 and 121 isolates along with others [22]. The probability of MSSA conversion to MRSA is perhaps high in India with the over use of antibiotics and its spread due to inadequate hygienic practices.
High prevalence of PVL and egc among the Indian MSSA and MRSA isolates is unlike the situation in Bangladesh, and Indonesia where only MSSA isolates contain PVL [12,23]. This indicates a possibility of PVL positive MSSA acquiring SCCmec elements to become PVL positive MRSA although this needs to be confirmed. A combination of PVLegc along with other entero-toxins could increase the severity of diseases caused by S. aureus although the role of PVL and other toxins is not completely elucidated [24,25]. There were no differences in the presence of the different virulence factors we characterized among the carrier isolates or the patient isolates.
Conclusion
This paper reports detailed molecular analysis of S. aureus isolates collected from different Indian cities and environments with their virulence factors for the first time. We have identified new and emerging STs as MRSA in addition to already reported ones in healthy carriers as well as patients. There are variant types of type IV and V SCCmec elements among MRSA. There is more diversity among the STs found in MSSA which may have the potential to acquire methicillin resistance. Majority of these isolates are PVL and egc positive. The detailed analysis of virulence factors might help in understanding of diseases caused and influence of host factors in those diseases.
Isolates and patients
Sixty eight S. aureus isolates were included in this study, 38 from healthy nasal carriers and 30 from infection sites. Isolates collected from nasal carriers from rural community and urban population between 2006 and 2008 were cultured. Carriers had no identified risk factors for MRSA acquisition which included prior hospitalization, use of antibiotics, and surgeries in the past year. Nasal swabs were collected after explaining the prepared questionnaire and with consent of the subjects. Isolates recovered from infected sites were from wounds, pleural fluid and blood cultures collected in patients from hospitals in Bengaluru, Mumbai, Delhi, and Hyderabad. Data on community origin of these isolates is limited to a few as the isolates were sent to us from physicians from different hospitals. Ethical clearances and written consents for publication were obtained from the respective hospitals.
Phenotypic characterization
S. aureus isolates were selected after growth on chromogenic agar medium (chromAgar, bioMérieux, Marcy-L’Etoile, France) and identified after characterization by Gram staining, detection of catalase, coagulase and DNAse as described elsewhere [26].
Antibiotic susceptibility testing
Susceptibility testing was performed by Kirby-Bauer disc diffusion according to the guidelines recommended by the CLSI (formerly NCCLS) on Mueller-Hinton agar plates at 37°C using antibiotic discs. Minimum Inhibitory Concentration (MIC) for oxacillin and cefoxitin was determined by the broth dilution method in Mueller-Hinton Broth after 24 hrs of incubation at 37°C in micro titer plates [27].
Chromosomal DNA isolation
Chromosomal DNA was extracted according to previously published procedures using lysostaphin [7].
PCR for detection of SCCmec elements and ccr types
SCCmec typing by determination of mec and ccr complexes for types IV and V SCCmec elements was carried out by multiplex PCR [28-30]. Subtyping of type IV SCCmec was performed according to the procedure of Zhang et al and Milherico et al [31,32].
Identification of accessory gene regulator (agr) alleles by PCR
The four agr alleles were determined by a multiplex PCR as described in Gilot et al [33].
Detection of toxins
The presence of PVL genes was detected by PCR using the published primers and procedure [34]. Presence of staphylococcal entero-toxins A, B, C, D and E, exfoliating toxins A and B and toxic shock syndrome toxin tst (TSST-1) and enterotoxin gene cluster (egc) cluster were detected by several multiplex PCRs using published procedures [35,36].
MLST and spa typing
MLST and spa typing were done as described earlier [37,38].
PFGE
PFGE was performed as described before [7].
eBURST analysis
Clonal relationship of the isolates was determined by using eBURST v3 program with the entire MLST database.
Microarray Analysis using CLONDIAG®
Microarray was performed for selected isolates from each of the clonal complexes. Diagnostic DNA microarray based on the Array/Tube platform (CLONDIAG, Jena, Germany) were utilized as described by Monecke et al [14]. The micro-array covers 185 distinct genes and about 300 alleles there of, including species- specific controls, agr alleles, genes including virulence factors, and microbial surface components recognizing adhesive matrix molecules (MSCRAMMS), capsule- type specific genes, as well as resistance determinants and immune evasion factors.
Authors’ contributions
SS, SN and SP have done the molecular characterization, and helped in organizing tables and figure, MB has planned and executed the microarray, GA has planned the study, executed and drafted the manuscript, JE has helped with microarray and editing the manuscript. All authors have read and approved the manuscript.
Supplementary Material
Additional file 1
Microarray data: Raw microarray data from 33 isolates representing different STs present in the total of 68 samples.
Acknowledgements
We are indebted to the clinicians who have given Staphylococcus aureus isolates and the financial support received by Department of Biotechnology, (Government of India), Sir Dorabji Tata Trust, Swedish International Development Agency to GA and from NPP-Indigo to JE.
  • Chambers HF, De Leo FR. Waves of resistance:Staphylococcus aureusin the antibiotic era. Nat Rev Microbiol. 2009;7:629–641. doi: 10.1038/nrmicro2200. [PMC free article] [PubMed] [Cross Ref]
  • Feng YC, Chen L, Su, Hu S, Yu J, Chiu C. Evolution and pathogenesis ofStaphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol. 2008;Rev. 32:23–37. [PubMed]
  • Popovich KJ, Weinstein RA, Hota B. Are community associated methicillin-resistantStaphylococcus aureus(MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46:787–794. doi: 10.1086/528716. [PubMed] [Cross Ref]
  • Ito T. International working group on the classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) Classification of Staphylococcal cassette chromosomemec(SCCmec): guidelines for reporting novel SCCmecelements. Antimicrob Agents Chemother. 2009;53:4961–4967. [PMC free article] [PubMed]
  • Li S, Skov RL, Han X, Larsen AR, Larsen J, Sorum M, Wulf M, Voss A, Hiramatsu K, Ito T. Novel types of staphylococcal cassette chromosomemecelements identified in CC398 methicillin resistantStaphylococcus aureusstrains. Antimicrob Agents Chemother. 2011;55:3046–3050. doi: 10.1128/AAC.01475-10. [PMC free article] [PubMed] [Cross Ref]
  • Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC. Detection of Staphylococcal Cassette ChromosomemecType XI Carrying Highly DivergentmecA, mecI, mecR1, blaZ,andccrGenes in Human Clinical Isolates of Clonal Complex 130 Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011 Aug;55(8):3765–3773. doi: 10.1128/AAC.00187-11. [PMC free article] [PubMed] [Cross Ref]
  • Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath S, Raghunath D. Genotyping of methicillin resistantStaphylococcus aureusstrains from two hospitals in Bangalore, South India. J Clin Microbiol. 2005;43:3198–3202. doi: 10.1128/JCM.43.7.3198-3202.2005. [PMC free article] [PubMed] [Cross Ref]
  • Nadig S, Namburi P, Raghunath D, Arakere G. Genotyping of methicillin resistantStaphylococcus aureusisolates from Indian Hospitals. Curr Sci. 2006;91:1364–1369.
  • Nadig S, Sowjanya SV, Seetharam S, Bharathi K, Raghunath D, Arakere G. In: Proceedings of the Ninth Sir Dorabji Tata Symposium on Antimicrobial resistance-The modern epidemic: Current Status and Research Issues: 10th-11th March 2008. Raghunath D, Nagaraja V, Durga Rao C, editor. Macmillan; 2009. Molecular characterization of Indian methicillin resistantStaphylococcus aureus; pp. 167–184.
  • Nadig S, Ramachandraraju S, Arakere G. Epidemic methicillin-resistantStaphylococcus aureusvariants detected in healthy and diseased individuals in India. J Med Microbiol. 2010;59:815–821. doi: 10.1099/jmm.0.017632-0. [PubMed] [Cross Ref]
  • D'Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistantStaphylococcus aureuswith emergence of epidemic clones of sequence type ST 22 and ST 772 in Mumbai. India J Clin Microbiol. 2010;48:1806–1811. [PMC free article] [PubMed]
  • Afroz SN, Kobayashi S, Nagashima MM, Alam AB, Hossain MA, Rahman MR, Islam AB, Lutfor N, Muazzam MA, Khan SK, Paul AK, Shamsuzzaman MC, Mahmud AK, Mahmud Musa, Hossain MA. Genetic characterization ofStaphylococcus aureusisolates carrying Panton-Valentine Leukocidin genes in Bangladesh. Jpn J Infect Dis. 2008;61:393–396. [PubMed]
  • Ghaznavi-Rad E, Shamsudin MN, Sekawi Z, Yun Khoon L, Nazri Aziz M, Hamat RA, Othman N, Chong PP, van Belkum A, Ghasemzadeh-Moghaddam H, Neela V. Predominance and emergence of clones of hospital-acquired methicillin-resistantStaphylococcus aureusin Malaysia. J Clin Microbiol. 2010;48:867–872. doi: 10.1128/JCM.01112-09. [PMC free article] [PubMed] [Cross Ref]
  • Monecke S, Slickers P, Ehricht R. Assignment ofStaphylococcus aureusisolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol. 2008;53:237–251. doi: 10.1111/j.1574-695X.2008.00426.x. [PubMed] [Cross Ref]
  • Heusser R, Ender M, Berger-Bachi B, McCallum N. Mosaic staphylococcal cassette chromosome mec containing two recombinase loci and a new mec complex, B2. Antimicrob Agents Chemother. 2007;51:390–393. doi: 10.1128/AAC.00921-06. [PMC free article] [PubMed] [Cross Ref]
  • Chen FJK, Hiramatsu IW, Huang C, Wang, Lauderdale TL. PVL positive methicillin susceptible and resistantStaphylococcus aureusin Taiwan: identification of oxacillin-susceptible mecA positive MRSA. Diagn Microbiol Infect Dis. 2009;65:351–357. doi: 10.1016/j.diagmicrobio.2009.07.024. [PubMed] [Cross Ref]
  • Ender M, McCallum N, Berger-Bachi B. Impact of mecA promoter mutations on mecA expression and beta lactam resistance levels. Int J Med Microbiol. 2008;298:607–617. doi: 10.1016/j.ijmm.2008.01.015. [PubMed] [Cross Ref]
  • Ghebremedhin B, Konig W, Witte W, Hardy KJ, Hawkey PM, Konig B. Subtyping of ST22-MRSA-IV (Barnim epidemic MRSA strain) at a university clinic in Germany from 2002 to 2005. J Med Microbiol. 2007;56:365–375. doi: 10.1099/jmm.0.46883-0. [PubMed] [Cross Ref]
  • Aires-de-Sousa MB, Correia, de Lencastre H. Multilaboratory Project Collaborators: Changing patterns in frequency of recovery of five methicillin-resistantStaphylococcus aureusclones in portugese hospitals: survelliance over a 16-year period. J Clin Microbiol. 2008;46:2912–2917. doi: 10.1128/JCM.00692-08. [PMC free article] [PubMed] [Cross Ref]
  • Hsu Li-Yang Y, Tse-Hsien Koh, Kurup A, Low J, Chlebicki P, Ban-Hock Tan. High incidence of Panton-Valentine Leukocidin producingStaphylococcus aureusin a tertiary care public hospital in Singapore. Clin Infect Dis. 2005;40:486–489. doi: 10.1086/427033. [PubMed] [Cross Ref]
  • Aires-de-Sousa MT, Conceicao C, Simas, de Lencastre H. Comparison of genetic backgrounds of methicillin resistant and susceptibleStaphylococcus aureusisolates from Portuguese hospitals and the community. J Clin Microbiol. 2005;43:5150–5157. doi: 10.1128/JCM.43.10.5150-5157.2005. [PMC free article] [PubMed] [Cross Ref]
  • Han L, Ho P, Ni Y, Zhang H, Jiang Y, Chu H, Sun Y, Zhang Y. Panton-Valentine Leukocidin-positive MRSA, Shanghai, China. Emerg Infect Dis. 2010;16:731–733. doi: 10.3201/eid1604.081324. [PMC free article] [PubMed] [Cross Ref]
  • Severin JA, Lestari ES, Kuntaman K, Melles DC, Pastink M, Peeters JK, Snijders SV, Hadi U, Duerink DO, van Belkum A, Verbrugh HA. Antimicrobial Resistance in Indonesia Prevalence and Prevention Study Group. Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitiveStaphylococcus aureusstrains carried in the Indonesian population. J Clin Microbiol. 2008;46:1989–1995. doi: 10.1128/JCM.01173-07. [PMC free article] [PubMed] [Cross Ref]
  • Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, Barbu EM, Vazquez V, Hook M, Etienne J, Vandenesch F, Bowden MG. Staphylococcus aureusPanton Valentine Leukocidin causes necrotizing pneumonia. Science. 2007;315:1130–1133. doi: 10.1126/science.1137165. [PubMed] [Cross Ref]
  • Diep BA, Palazzolo-Balance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, Deleo FR, Chambers HF. Contribution of Panton-Valentine Leukocidin in community-associated methicillin-resistantStaphylococcus aureuspathogenesis. PLoS One. 2008;3:e3198. doi: 10.1371/journal.pone.0003198. [PMC free article] [PubMed] [Cross Ref]
  • Baird D. In: Practical Medical Microbiology. Collee JG, Fraser AG, Marmion BP, Simmons A, editor. 1996. Staphylococcus: cluster-forming gram positive cocci; pp. 245–261.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa; 2005. CLSI/NCCLS document M100-S15.
  • Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin resistantStaphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155–2161. doi: 10.1128/AAC.46.7.2155-2161.2002. [PMC free article] [PubMed] [Cross Ref]
  • Kondo Y, Ito T, Ma XX, Watanabe S, Kreiswirth BN, Etienne J, Hiramatsu K. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother. 2007;51:264–274. doi: 10.1128/AAC.00165-06. [PMC free article] [PubMed] [Cross Ref]
  • Milheirico C, Oliveira DC, de Lencastre H. Update to the multiplex PCR strategy for the assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:3374–3377. doi: 10.1128/AAC.00275-07. [PMC free article] [PubMed] [Cross Ref]
  • Zhang K, McClure J, Elsayed S, Louie T, Conly JM. Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette Chromosome mec Types I to V in Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:5026–5033. doi: 10.1128/JCM.43.10.5026-5033.2005. [PMC free article] [PubMed] [Cross Ref]
  • Milheirico C, Oliveira DC, de Lencastre H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: ‘SCCmec IV multiplex’ J Antimicrob Chemother. 2007;60:42–48. doi: 10.1093/jac/dkm112. [PubMed] [Cross Ref]
  • Gilot P, Lina G, Cochard T, Poutrel B. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population ofStaphylococcus aureusstrains isolated from cows with mastitis. J Clin Microbiol. 2002;40:4060–4067. doi: 10.1128/JCM.40.11.4060-4067.2002. [PMC free article] [PubMed] [Cross Ref]
  • Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. Involvement of Panton-Valentine leukocidin-producingStaphylococcus aureusin primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–1132. doi: 10.1086/313461. [PubMed] [Cross Ref]
  • Mehrotra M, Wang G, Johnson WM. Multiplex PCR for detection of genes forStaphylococcus aureusenterotoxins, exfoliative toxins, toxic shock syndrome toxin1, and methicillin resistance. J Clin Microbiol. 2000;38:1032–1035. [PMC free article] [PubMed]
  • Jarraud S, Cozon G, Vandenesch F, Bes M, Etienne J, Lina G. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol. 1999;37:2446–2449. [PMC free article] [PubMed]
  • Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin resistant and methicillin susceptible clones ofStaphylococcus aureus. J Clin Microbiol. 2000;38:1008–1015. [PMC free article] [PubMed]
  • Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S, Kreiswirth BN. Evaluation of protein A gene polymorphic region DNA sequencing for typing ofStaphylococcus aureusstrains. J Clin Microbiol. 1999;37:3556–3563. [PMC free article] [PubMed]
Articles from BMC Microbiology are provided here courtesy of
BioMed Central